Biopharma Update on the Novel Coronavirus: June 26
Rockwell Medical, Inc. Receives FDA Approval for Triferic AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients - FirstWord Pharma
Biopharma Industry News for March 27: Update on the Novel Coronavirus
Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19
SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19 - FirstWord Pharma
- Advertisement -

LATEST NEWS

MUST READ